These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6231779)

  • 1. [Efficacy and tolerance of hepatitis B vaccination in medical personnel and hemodialysis patients].
    Horak W; Leithner C; Kemenesi W; Pinggera W
    Wien Klin Wochenschr; 1984 Feb; 96(4):161-5. PubMed ID: 6231779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with vaccination against hepatitis B].
    Kunz C; Hofmann H; Frisch-Niggemeyer W
    Wien Klin Wochenschr; 1984 Feb; 96(4):158-61. PubMed ID: 6231778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
    Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
    Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B vaccination].
    Descoeudres C
    Schweiz Med Wochenschr; 1984 Apr; 114(15):498-505. PubMed ID: 6729415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against hepatitis B in a hemodialysis unit. A 4-year follow up (author's transl)].
    Pengloan J; Bagros P; Jourdan JL; Nivet H; Goudeau A; Dubois F; Barin F
    Nephrologie; 1982; 3(1):32-5. PubMed ID: 7088262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
    Di Giandomenico G; Di Giandomenico FW; Volterrani A
    Minerva Med; 1989 Feb; 80(2):149-51. PubMed ID: 2927706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
    Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
    Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.
    Fernández E; Betriu MA; Gómez R; Montoliu J
    Nephrol Dial Transplant; 1996 Aug; 11(8):1559-63. PubMed ID: 8856211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of hepatitis B vaccination (HEVAC B) in healthy subjects and haemodialysis patients.
    van Beers D; Liesnard C; Duys M; Etienne J; Cappel R
    Dev Biol Stand; 1983; 54():163-9. PubMed ID: 6228455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
    Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
    N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W
    Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
    Bock M; Barros E; Veronese FJ
    Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.